Carlyle Group’s QuidelOrtho QDEL Stock Holding History

Carlyle Group’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8,260,183	Closed	-$377M	–	29
2024 Q3	$377M	Sell	8,260,183 -3,260,568	-28%	-$132M	39.47%	1
2024 Q2	$383M	Sell	11,520,751 -939,432	-8%	-$38.4M	36.35%	1
2024 Q1	$597M	Hold	12,460,183	–	–	37.66%	1
2023 Q4	$918M	Hold	12,460,183	–	–	44.17%	1
2023 Q3	$910M	Hold	12,460,183	–	–	39.47%	1
2023 Q2	$1.03B	Hold	12,460,183	–	–	36.78%	1
2023 Q1	$1.11B	Hold	12,460,183	–	–	33.11%	1
2022 Q4	$1.07B	Hold	12,460,183	–	–	31.06%	2
2022 Q3	$891M	Hold	12,460,183	–	–	28.28%	2
2022 Q2	$1.21B	Buy	+12,460,183	New	+$1.27B	20.88%	3

Other funds holding QDEL

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Carlyle Group's QDEL Position: Q4 2024 in Review

Carlyle Group sold out of QuidelOrtho (QDEL) in Q4 2024, closing a stake of 8,260,183 shares — an estimated $377M sold.

Carlyle Group first reported a position in QDEL in Q2 2022 and held it in 10 quarters. The position peaked at $1.21B in Q2 2022. 275 funds tracked by Wall St. Rank hold QDEL as of Q4 2024.

Carlyle Group reported no remaining QuidelOrtho position as of Q4 2024 after selling out during the quarter.
Carlyle Group sold 8,260,183 QuidelOrtho shares in Q4 2024, an estimated $377M.
Carlyle Group first reported a position in QuidelOrtho in Q2 2022 and held it in 10 quarters.
Carlyle Group's QuidelOrtho position peaked at $1.21B in Q2 2022.
275 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2024.

Based on Carlyle Group's 13F filing for Q4 2024, filed 13 Feb 2025.